stockrowAlvotech (ALVO) vs Eton Pharmaceuticals, Inc. (ETON)
- Alvotech ALVO 4.58 −1.93%
- Eton Pharmaceuticals, Inc. ETON 47.45 −6.45%
Alvotech and Eton Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $1.8B against $1.4B — 1.3× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; Eton Pharmaceuticals, Inc. trades at 26.8×. Alvotech grew revenue faster over the last twelve months: 364.3% against 100.6%. Eton Pharmaceuticals, Inc. has the higher net margin (35.4% vs −101.1%) and the higher return on invested capital (46.8% vs 0.00%). Across the 16 metrics below, Eton Pharmaceuticals, Inc. leads on 11 and Alvotech on 5.
Valuation
Profitability
| Metric | ALVO | ETON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 69.15% | 53.51% |
| Operating margin | (42.43%) | 28.84% | 0.00% |
| Net margin | (101.05%) | 35.35% | (2.45%) |
| Free cash flow margin | 0.00% | 14.17% | 0.00% |
| Return on equity | 0.00% | 90.62% | (0.80%) |
| Return on assets | 0.00% | 38.10% | (1.67%) |
| Return on invested capital | 0.00% | 46.77% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack